INH2BP

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameINH2BP
Drug Alias NameINH 2-BPINH2-BPINH-2 BPINH-2BP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsDiabetes Mellitus, Type 1Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInotek Pharmaceuticals CorporationUniversity Of PittsburghRocket Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInotek Pharmaceuticals CorporationUniversity Of Pittsburgh
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Stroke

Other Information

ATC CodeN/A
Related LinksN/A